<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Epidemiology of gastric cancer
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Epidemiology of gastric cancer
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Epidemiology of gastric cancer
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Annie On On Chan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Benjamin Wong, DSc, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mark Feldman, MD, MACP, AGAF, FACG
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sonali M Shah, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 24, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer has been described as early as 3000 BC in hieroglyphic inscriptions and papyri manuscripts from ancient Egypt. The first major statistical analysis of cancer incidence and mortality (using data gathered in Verona, Italy from 1760 to 1839) showed that gastric cancer was the most common and lethal cancer. It has remained one of the most important malignant diseases, with significant geographic and regional differences in distribution.
        </p>
        <p>
         Gastric adenocarcinomas are primarily classified topographically as cardia (proximal or upper stomach) and non-cardia (lower stomach) based on their anatomic site  (
         <a class="graphic graphic_figure graphicRef79793" href="/z/d/graphic/79793.html" rel="external">
          figure 1
         </a>
         ). Cancers of the gastric cardia arise in the region adjoining the esophageal-gastric junction and thus share epidemiologic characteristics with esophageal adenocarcinoma (EAC). Non-cardia cancer, also known as distal stomach cancer, is more common and arises in the lower portion of the stomach.
        </p>
        <p>
         The epidemiology of gastric cancer is presented here. Risk factors for gastric cancer are presented separately. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H91192772">
         <span class="h1">
          INCIDENCE
         </span>
        </p>
        <p class="headingAnchor" id="H1034625052">
         <span class="h2">
          Global incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer is the fifth leading cause of cancer worldwide [
         <a href="#rid1">
          1
         </a>
         ]. Global and country-specific incidence rates are available in the World Health Organization
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fgco.iarc.fr%2F&amp;token=papEJRwmxEbzVq8Z5Cy8HpHRmuU6GAJR2OxnHjUvdx0%3D&amp;TOPIC_ID=2616" target="_blank">
          GLOBOCAN database
         </a>
         (
         <a class="graphic graphic_figure graphicRef140979" href="/z/d/graphic/140979.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The incidence of gastric cancer varies worldwide by geographic region as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The highest incidence rates are in Eastern Asia (Mongolia, China, South Korea, and Japan), the Andean regions of South America, and Eastern Europe [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The lowest incidence rates are in North America, Northern Europe, and most countries in Africa and South Eastern Asia [
         <a href="#rid4">
          4
         </a>
         ]. In the United States, over 26,000 patients are diagnosed with gastric cancer annually, and over 11,000 are expected to die from this disease [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A majority (over 70 percent) of gastric cancers occur in resource-limited countries [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Notably, the global incidence of gastric cancer has declined rapidly over the past few decades [
         <a href="#rid6">
          6-10
         </a>
         ]. Part of the decline may be due to the recognition of certain risk factors such as
         <em>
          Helicobacter pylori
         </em>
         and other dietary and environmental risks. However, the decline clearly began before the discovery of
         <em>
          H. pylori
         </em>
         . The popularization of refrigerators marks a pivotal point for the decline in incidence [
         <a href="#rid11">
          11,12
         </a>
         ]. It is hypothesized that refrigerators improved the storage of food, thereby reducing salt-based preservation of food and preventing bacterial and fungal contamination. Refrigeration also allowed for fresh food and vegetables to be more readily available, which may be a valuable source of antioxidants important for cancer prevention. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer", section on 'Environmental risk factors'
         </a>
         .)
        </p>
        <p>
         The rate of decline in the incidence of gastric cancer also varies between countries and regions. The decline first took place in countries with low gastric cancer incidence such as the United States (beginning in the 1930s), while the decline in countries with high incidence like Japan was slower. In the United Kingdom, there has been a consistent decline in incidence of gastric cancer, with a reduction in relative risk from 1.14 in 1971 to 1975 to 0.84 in 1996 to 2000 in males, and 1.18 in 1971 to 1975 to 0.81 in 1996 to 2000 in females [
         <a href="#rid13">
          13
         </a>
         ]. In China, the decline has been less dramatic as compared with other countries. Despite an overall decrease in gastric cancer incidence in China, the incidence of early-onset gastric cancer is increasing [
         <a href="#rid3">
          3
         </a>
         ]. The decreasing trends in age-standardized incidence and mortality rates have been more pronounced in females than in males [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Regional variation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional variations in the incidence of gastric cancer have also been observed, as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migration patterns
         </strong>
         – Migration, and in particular, international migration, can lead to a change in risk, as the immigrants, especially second and third generations, adopt the lifestyle and consequently the local disease patterns. Emigrants from high-incidence to low-incidence countries often experience a decreased risk of developing gastric carcinoma. Such findings strongly suggest that environmental factors have an important role in the etiology of gastric cancer and that exposure to risk factors occurs early in life. Studies of Japanese migrants to the Unites States have confirmed that early exposure to environmental rather than genetic factors have a greater influence on mortality and incidence rates [
         <a href="#rid14">
          14,15
         </a>
         ]. In the subsequent generations born in the United States, the mortality rate declined towards the lower rate of White Americans.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Regional variation from north to south
         </strong>
         – A difference in incidence and mortality from north to south has been observed in several countries, with the northern areas having a higher mortality risk than those in the south. This gradient is particularly marked in the northern hemisphere [
         <a href="#rid16">
          16-18
         </a>
         ], whereas in the southern hemisphere, the mortality risk tends to be higher in the southern parts [
         <a href="#rid19">
          19,20
         </a>
         ]. In Japan, there appears to be a north/south divide, with gastric cancer mortality and incidence higher in the northeastern prefectures [
         <a href="#rid21">
          21
         </a>
         ]. In England and Wales, there is a twofold difference in mortality and incidence rates across the country, with lower levels in the south and east and higher levels in the north and west, particularly noticeable in northwest Wales [
         <a href="#rid22">
          22
         </a>
         ]. In China, the incidence and mortality of gastric cancer varies from province to province (generally very high in the north, but relatively low in the south) [
         <a href="#rid18">
          18,23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3445550052">
         <span class="h2">
          Sex
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of gastric cancer is higher in males than in females, in both resource-abundant and resource-limited countries  (
         <a class="graphic graphic_figure graphicRef140979" href="/z/d/graphic/140979.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1136068297">
         <span class="h2">
          Time trends
         </span>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Changes in histologic pattern
         </span>
         <span class="headingEndMark">
          —
         </span>
         The two main histologies of gastric cancer are intestinal and diffuse type. These histologies represent two biological entities that differ with regard to epidemiology, etiology, pathogenesis, and behavior. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'Intestinal versus diffuse types'
         </a>
         .):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intestinal type
         </strong>
         – Intestinal gastric cancer is more common in males and older age groups. It is more prevalent in high-risk areas and is likely linked to environmental factors.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diffuse type
         </strong>
         – The diffuse or infiltrative type is equally frequent in both sexes, is more common in younger age groups, and has a worse prognosis than the intestinal type.
        </p>
        <p>
        </p>
        <p>
         There has been a worldwide decline in the incidence of the intestinal type that parallels the overall decline in the incidence of gastric cancer. By contrast, the decline in the diffuse type has been more gradual. As a result, the diffuse type now accounts for approximately 30 percent of gastric carcinoma in some reported series [
         <a href="#rid16">
          16,17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2528667141">
         <span class="h3">
          Proximal tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the decline in gastric cancer overall, there has been a dramatic increase in incidence of cancer of the gastric cardia  (
         <a class="graphic graphic_figure graphicRef79793" href="/z/d/graphic/79793.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid18">
          18
         </a>
         ]. The shift from distal to proximal stomach may in part be due to the decrease in the distal cancers. However, it has also been proposed that carcinoma at the cardia is a different entity from that of the rest of the gastric carcinoma.
        </p>
        <p>
         The proximal tumors share demographic and pathologic features with Barrett's-associated esophageal adenocarcinoma and are more likely to occur in males, which parallels the male predominance in the increasing incidence of carcinoma in the lower third of the esophagus. The proximal tumors also differ from distal tumors in that they are not associated with a severe form of gastritis characterized by atrophy and/or intestinal metaplasia. Furthermore, they tend to be more aggressive than those arising from distal sites. Environmental factors or chemical carcinogens (eg, cigarette and alcohol) may be more strongly associated with cardiac carcinomas compared with more distal carcinomas [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2274.html" rel="external">
          "Epidemiology and pathobiology of esophageal cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1986352635">
         <span class="h3">
          Rise in incidence in younger adults
         </span>
         <span class="headingEndMark">
          —
         </span>
         There has been an increase in the incidence of gastric cancer (cardia and non-cardia gastric cancers combined) among young adults (aged &lt;50 years) in both low-incidence and high-incidence countries [
         <a href="#rid20">
          20-22
         </a>
         ]. It is unclear if the rising prevalence of autoimmune gastritis and dysbiosis secondary to the increased use of antibiotics and acid suppressants has led to an increase in incidence in younger adults [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H647749897">
         <span class="h1">
          MORTALITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer is the fourth leading cause of cancer deaths worldwide [
         <a href="#rid4">
          4
         </a>
         ]. Mortality rates are high because most patients with gastric cancer present with advanced disease [
         <a href="#rid24">
          24
         </a>
         ]. However, there has been a steady decline in gastric cancer mortality worldwide, with the rate of decline varying by region [
         <a href="#rid4">
          4,23
         </a>
         ]. Global and country-specific mortality rates are available in the World Health Organization
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fgco.iarc.fr%2F&amp;token=papEJRwmxEbzVq8Z5Cy8HpHRmuU6GAJR2OxnHjUvdx0%3D&amp;TOPIC_ID=2616" target="_blank">
          GLOBOCAN database
         </a>
         [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Observational data also suggest that mortality from gastric cancer differs by race and ethnicity. In the United States, gastric cancer mortality rates are lower in White Americans (2.1 per 100,000) compared with those who identify as American Indian/Alaska Native (5.5 per 100,000), Black (5 per 100,000), Hispanic/Latino (4.8 per 100,000), or Asian American/Pacific Islander (4.6 per 100,000) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2759009504">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114875.html" rel="external">
          "Society guideline links: Gastric cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – Gastric cancer is a leading cause of cancer worldwide. (See
         <a class="local">
          'Global incidence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The incidence of gastric cancer varies worldwide by geographic region  (
         <a class="graphic graphic_figure graphicRef140979" href="/z/d/graphic/140979.html" rel="external">
          figure 2
         </a>
         ). The highest incidence rates are in Eastern Asia, the Andean regions of South America, and Eastern Europe, while the lowest rates are in North America, Northern Europe, and most countries in Africa and South Eastern Asia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The global incidence of gastric cancer has declined rapidly over the past few decades, but the rate of decline varies between countries and regions. This decline may be due to the recognition of certain risk factors such as
         <em>
          H. pylori
         </em>
         and other dietary and environmental risks. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer", section on 'Environmental risk factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other regional factors also impact incidence, such as migration patterns. (See
         <a class="local">
          'Regional variation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Important trends in gastric cancer incidence
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Histology
         </strong>
         – There is a more dramatic decline in the worldwide incidence of intestinal type compared with diffuse type gastric cancer. The decline in the incidence of the intestinal type parallels the overall decline in the incidence of gastric cancer; by contrast, the decline in the incidence of the diffuse type has been more gradual. (See
         <a class="local">
          'Changes in histologic pattern'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Location
         </strong>
         – There is an increase in incidence of cancer of the gastric cardia  (
         <a class="graphic graphic_figure graphicRef79793" href="/z/d/graphic/79793.html" rel="external">
          figure 1
         </a>
         ). The shift from distal to proximal stomach may in part be due to the decrease in the distal cancers. (See
         <a class="local">
          'Proximal tumors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Age
         </strong>
         – There is an increase in the incidence of gastric cancer (cardia and non-cardiac gastric cancers combined) among young adults (aged &lt;50 years) in both low-incidence and high-incidence countries. (See
         <a class="local">
          'Rise in incidence in younger adults'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mortality
         </strong>
         – Gastric cancer is the fourth leading cause of cancer deaths worldwide. Mortality rates are high because most patients with gastric cancer present with advanced disease. However, there has been a steady decline in gastric cancer mortality worldwide, with the rate of decline varying by region. (See
         <a class="local">
          'Mortality'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine 2022; 47:101404.
          </a>
         </li>
         <li class="breakAll">
          Global Cancer Observatory. International Agency for Research on Cancer. World Health Organization. Available at: https://gco.iarc.fr/ (Accessed on December 13, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           He Y, Wang Y, Luan F, et al. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med 2021; 10:3461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           HAENSZEL W. Variation in incidence of and mortality from stomach cancer, with particular reference to the United States. J Natl Cancer Inst 1958; 21:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz N, Asvall J. Time trends of intestinal and diffuse types of gastric cancer in Norway. Int J Cancer 1971; 8:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirayama T. Epidemiology of cancer of the stomach with special reference to its recent decrease in Japan. Cancer Res 1975; 35:3460.
          </a>
         </li>
         <li class="breakAll">
          Cancer incidence in five continents. Waterhouse J, Muir C, Correa P, et al (Eds), Vol III, IARC Scientific Publication no.15, International Agency for Research on Cancer, Lyon 1976.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhu AL, Sonnenberg A. Is gastric cancer again rising? J Clin Gastroenterol 2012; 46:804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coggon D, Barker DJ, Cole RB, Nelson M. Stomach cancer and food storage. J Natl Cancer Inst 1989; 81:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           La Vecchia C, Negri E, D'Avanzo B, Franceschi S. Electric refrigerator use and gastric cancer risk. Br J Cancer 1990; 62:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzsimmons D, Osmond C, George S, Johnson CD. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000. Br J Surg 2007; 94:1162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haenszel W, Kurihara M, Segi M, Lee RK. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972; 49:969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ikeda Y, Mori M, Kamakura T, et al. Improvements in diagnosis have changed the incidence of histological types in advanced gastric cancer. Br J Cancer 1995; 72:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korivi BR, Faria S, Aly A, et al. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites. Clin Imaging 2019; 56:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalish RJ, Clancy PE, Orringer MB, Appelman HD. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology 1984; 86:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health 2019; 4:e137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011; 60:1644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Ren N, Zhang B, et al. Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age-period-cohort patterns. Cancer 2023; 129:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125:666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soerjomataram I, Cabasag C, Bardot A, et al. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol 2023; 24:22.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2616 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35497064" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35497064" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33931958" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chinese and global burdens of gastric cancer from 1990 to 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33538338" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36633525" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Cancer statistics, 2023.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13576088" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Variation in incidence of and mortality from stomach cancer, with particular reference to the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5118205" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Time trends of intestinal and diffuse types of gastric cancer in Norway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1192411" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Epidemiology of cancer of the stomach with special reference to its recent decrease in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1192411" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Epidemiology of cancer of the stomach with special reference to its recent decrease in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22914346" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Is gastric cancer again rising?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2746670" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Stomach cancer and food storage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2390474" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Electric refrigerator use and gastric cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17520709" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5635018" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4678140" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Stomach cancer among Japanese in Hawaii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7640228" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Improvements in diagnosis have changed the incidence of histological types in advanced gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30870726" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2206952" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6693012" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30733056" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21613644" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36284481" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age-period-cohort patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19382179" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Recent patterns in gastric cancer: a global overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36603919" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
